1. Home
  2. ACIW vs GRFS Comparison

ACIW vs GRFS Comparison

Compare ACIW & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ACI Worldwide Inc.

ACIW

ACI Worldwide Inc.

HOLD

Current Price

$49.19

Market Cap

5.1B

Sector

Technology

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$7.44

Market Cap

5.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACIW
GRFS
Founded
1975
1940
Country
United States
Spain
Employees
2930
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1B
5.0B
IPO Year
1996
2008

Fundamental Metrics

Financial Performance
Metric
ACIW
GRFS
Price
$49.19
$7.44
Analyst Decision
Strong Buy
Hold
Analyst Count
4
2
Target Price
$62.50
$10.15
AVG Volume (30 Days)
648.2K
358.8K
Earning Date
05-07-2026
07-28-2022
Dividend Yield
N/A
1.80%
EPS Growth
13.09
N/A
EPS
0.69
N/A
Revenue
$1,009,780,000.00
N/A
Revenue This Year
$9.67
$4.49
Revenue Next Year
$7.41
$6.42
P/E Ratio
$71.87
$18.67
Revenue Growth
N/A
N/A
52 Week Low
$38.05
$6.96
52 Week High
$61.08
$10.23

Technical Indicators

Market Signals
Indicator
ACIW
GRFS
Relative Strength Index (RSI) 38.03 39.33
Support Level $38.92 $7.26
Resistance Level $54.10 $8.41
Average True Range (ATR) 1.26 0.11
MACD -0.21 -0.04
Stochastic Oscillator 12.92 13.87

Price Performance

Historical Comparison
ACIW
GRFS

About ACIW ACI Worldwide Inc.

ACI Worldwide Inc develops, markets, and installs a portfolio of software products focused on facilitating electronic payments. The firm's products are sold and supported directly and through distribution networks covering three geographic regions - the Americas, EMEA, and Asia Pacific. ACI software products process payment transactions for retail banking clients, billers such as utilities and healthcare providers, and community banks and credit unions. ACI's customers are financial institutions all over the world, but the majority of the revenue is generated in the United States and EMEA regions. The company's operating segment includes Payment Software and Biller. The company generates the majority of its revenue from the Payment Software segment.

About GRFS Grifols S.A.

Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.

Share on Social Networks: